Proprietary Technology: Ingenza Biologics offers proprietary gene optimization (inABLE™) and culture development technology to rapidly deliver high product yielding cultures and optimized product performance, enabled by protein engineering and resulting in high product value and production efficiency. We also operate unique high throughput cloning and screening methodologies, coupled to high cell-density microbial fermentation and cell culture processes to meet client timing and specifications.
Manufacturing Systems: In the UK and through its strategic partners, Ingenza Biologics offers GMP-certified facilities, validated equipment and trained personnel to deliver recombinant proteins, nucleic acids, cells, and fill-finish products. Research, pre-clinical and clinical materials are manufactured using high-yield expression systems, efficient downstream processing and client-defined bioanalytics. Single use manufacturing systems maximize quality and efficiency while maintaining high cost-competitiveness.
Quality: Our highly dedicated teams deliver to clients a full range of analytical services, quality assurance, product characterization, documentation, and regulatory support for US and EU submissions.
Versatility: We provide advanced technology in mammalian, insect and microbial expression systems, cell banking, upstream, downstream, and bioanalytics for the biomanufacturing of cellular and gene therapy products, recombinant proteins, and formulated fill/finished drugs. Production technology based on multi-product facilities applying novel single use systems results in maximum flexibility for project scheduling and performance.